Babbage from The Economist

Babbage: A flicker of light for Alzheimer’s

06.08.2021 - By The EconomistPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

After almost two decades, the FDA has granted conditional approval to a drug for the treatment of Alzheimer’ disease, called aducanumab. But the new drug, and its approval, is surrounded by controversy. Will the gamble pay off? Also, a clever upgrade to fog-collecting technology which could provide a water source in remote locations. And, potentially life-saving oxygen enemas? Kenneth Cukier hosts 

For full access to The Economist’s print, digital and audio editions subscribe at economist.com/podcastoffer and sign up for our new weekly science newsletter at economist.com/simplyscience. Hosted on Acast. See acast.com/privacy for more information.

More episodes from Babbage from The Economist